Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients

AIM: Soluble suppression of tumorigenicity‐2 (sST2) is a strong prognostic biomarker in heart failure. The emerging understanding of circadian biology in cardiovascular disease may lead to novel applications in prognosis and diagnosis and may provide insight into mechanistic aspects of the disease–b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Crnko, Sandra, Printezi, Markella I., Jansen, Tijn P.J., Leiteris, Laurynas, van der Meer, Manon G., Schutte, Hilde, van Faassen, Martijn, du Pré, Bastiaan C., de Jonge, Nicolaas, Asselbergs, Folkert W., Gaillard, Carlo A.J.M., Kemperman, Hans, Doevendans, Pieter A., Sluijter, Joost P.G., van Laake, Linda W.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7261542/
https://ncbi.nlm.nih.gov/pubmed/32233077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12673
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados